|
|
|
|
![]()
|
The immunoglobulin free light chain assay (FREELITE, Binding Site, Birmingham, UK) is a very important assay that has been in use for nearly a decade. Its importance has been growing over time, and new uses for it have also been emerging. |
|
|
|
|
|
In individuals with myeloma and related disorders such as monoclonal gammopathy of undetermined significance (MGUS), excess light chains enter the bloodstream. as free light chains. The amount of free light chain production is linked to the activity of myeloma or plasma cell growth. |
|
|
|
|
|
Basic information about the Freelite Test, including what are free light chains, why is the test used, how accurate is it, and if it is covered by insurance. |
|
|
|
|
![]()
|
The following guidelines from the International Myeloma Working Group describe the potential uses of the serum free light chain (SFLC) assay and distinguish which uses have proved their utility and which are still undergoing investigation. |
|
|
|
The FreeLite Test
Mike Katz, IMF Board Member
|
|
![]()
|
To view the video full screen, click on
the small  button next to the volume
control in the lower right hand corner. |
|
|
|
Understanding Serum Free Light Chain Assays
Dr. Karen Van Hoeven, The Binding Site
|
|
![]()
|
To view the video full screen, click on
the small button next to the volume
control in the lower right hand corner. |
|
|
|
|
|
This new test from The Binding Site measures free Lambda and Kappa light chains in the blood. The test is particularly useful for patients with non-secretory myeloma and is also being considered as a potential replacement for the 24 hour urine test |
|
|
|
step 1: get the correct diagnosis
step 2: tests you really need
print
back to top